Our in vivo results identifying FABP4, IL-1β and HMOX-1 as factors influencing invasiveness and tumor growth in the bone but not in the subcutaneous site were recapitulated using bone marrow adipocyte cultures in vitro. The gene discussed is FABP4; the disease is neoplasm.